Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XAZECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
XAZECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XAZEHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XAZEHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XAZENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XAZENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BE.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BE.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BE.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BE.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BE.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BE.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.24EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.1.24EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.24ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.5.1.24ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.5.1.24EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.1.24EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.1.24ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.1.24ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BT.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BT.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BT.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BT.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BT.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BT.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BT.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BT.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.55EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.2.55EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.55ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.5.2.55ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.5.2.55EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.2.55EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.2.55ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.55ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.76EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.76EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.76ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.2.76ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.2.76EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2.76EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.76ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.76ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.30EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.1.30EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.30ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.5.1.30ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used